Clinical Trial Update: Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study. [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial evaluated the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Infertility

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Asthma, Infertility, Female | Phase 2 | Status: COMPLETED